FDA’s Proposed Sunscreen Rule Could Bring SPFs Back Down To Earth, Deter SPF Fraud Suits
Executive Summary
SPF claims would be capped at SPF 60+ under FDA’s proposed rule, and companies would be required to label products using the lowest SPF measured in testing and maintain test records that would be accessible to FDA during inspections. The proposal also includes new broad-spectrum requirements, among a host of other changes.
You may also be interested in...
UK Sunscreen Claims On ‘Negligible’ Difference In SPF Strengths Don't Add Up
Advertising Standards Authority says Green People Co. misled consumers with claims SPF 30 formulas filter out only 1% less UVB rays than SPF 50, trying to draw a negligible difference between the formulas. The claims appeared in a direct mailer and on the brand’s website in July 2019.
Proposed Sunscreen Monograph Hikes Costs, Increases Prices – CHPA, PCPC
Changes in tentative final OTC sunscreen monograph would increase testing costs than FDA estimates and leave consumers with fewer, more expensive products to choose from, say CHPA and PCPC. Firms estimate testing costs will increase roughly 25% to 30% based on proposed changes in protocols.
SPF Testing Costs (And Variability) Could Be Reduced With In Vitro Method Uptake
Cosmetics Europe expects its in vitro method for SPF determination to be a published ISO standard within two to three years. The European Commission is behind in vitro sunscreen testing, and the method could significantly reduce costs and technical challenges while providing in vivo-equivalent results, the trade group says.